- Home
- AAPG vs RQI Comparison
AAPG vs RQI Comparison
Compare AAPG & RQI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | AAPG | RQI |
|---|---|---|
| Founded | 2009 | 2002 |
| Country | China | United States |
| Employees | 767 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Trusts Except Educational Religious and Charitable |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 1.7B |
| IPO Year | N/A | 2001 |
Fundamental Metrics
Financial Performance| Metric | AAPG | RQI |
|---|---|---|
| Price | $16.81 | $12.61 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $48.40 | N/A |
| AVG Volume (30 Days) | 4.8K | ★ 854.6K |
| Earning Date | 05-20-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 8.20% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $290.34 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $16.36 | $11.30 |
| 52 Week High | $48.45 | $13.57 |
Technical Indicators
Market Signals| Indicator | AAPG | RQI |
|---|---|---|
| Relative Strength Index (RSI) | 36.75 | 53.80 |
| Support Level | $16.64 | $12.06 |
| Resistance Level | $18.17 | $13.47 |
| Average True Range (ATR) | 0.45 | 0.17 |
| MACD | -0.23 | 0.05 |
| Stochastic Oscillator | 0.00 | 70.92 |
Price Performance
Historical ComparisonAbout AAPG Ascentage Pharma Group International American Depository Shares
Ascentage Pharma Group International is a clinical-stage biotechnology company engaged in the development and sales of novel small-scale therapies for cancers, hepatitis B virus, or HBV, and certain age-related diseases. It focuses on developing therapies that inhibit protein-protein interactions to restore apoptosis or programmed cell death. The Group has one reportable operating segment, which is discovering, developing, and commercializing therapies to address medical needs in hematological malignancies and currently has seven drug candidates in pipeline under research. The company's geographical segments include the United States and Mainland China.
About RQI Cohen & Steers Quality Income Realty Fund Inc
COHEN & STEERS QUALITY INCOME REALTY FUND INC is a diversified, closed-end management investment company. The primary investment objective of the fund is high current income through investment in real estate securities. The Fund's secondary objective is capital appreciation. The Fund invests at least its total assets in income-producing common stocks and other securities issued by real estate companies, such as real estate investment trusts under normal market conditions.